Insights

Non-surgical sterilization Epivara offers iSpay and iNeuter, a non-surgical, single-injection sterilization solution. This creates a compelling value proposition for shelters, humane organizations, and farm operations seeking humane, cost-effective population control with minimal animal distress.

NSF and SBIR backing The company has secured multiple SBIR grants from NSF and USDA, signaling robust validated R&D potential and potential government funding avenues for customer-facing pilots, co-development, or procurement partnerships.

Cost and accessibility Technology is described as inexpensive and easy to administer, which positions Epivara well to win bids from shelters, rescue networks, and rural farms that require scalable, budget-conscious fertility management solutions.

Global animal welfare impact By reducing aggression and sexual behavior through decreased hormone production, Epivara’s solution aligns with welfare-focused buyers and livestock producers looking to improve animal well-being and reduce management challenges.

Growth and funding signals Recent grant activity, recognition prizes, and a revenue range of one to ten million with millions in funding indicate a growing company with potential for early adopter programs, pilot deployments, and strategic partnerships in veterinary and agricultural channels.

Similar companies to Epivara

Epivara Tech Stack

Epivara uses 8 technology products and services including QuickBooks, Usercentrics, Wix, and more. Explore Epivara's tech stack below.

Media & News

Epivara's Email Address Formats

Epivara uses at least 1 email format:
Epivara Email FormatsExamplePercentage
First@epivara.comJohn@epivara.com
100%

Frequently Asked Questions

What is Epivara's official website and social media links?

Minus sign iconPlus sign icon
Epivara's official website is epivara.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Epivara generate?

Minus sign iconPlus sign icon
As of November 2026, Epivara's annual revenue is estimated to be $1M - $10M.

What is Epivara's NAICS code?

Minus sign iconPlus sign icon
Epivara's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Epivara have currently?

Minus sign iconPlus sign icon
As of November 2026, Epivara has approximately 14 employees across 1 continents, including North America. Key team members include Director Or Marketing And Brand: J. S. Explore Epivara's employee directory with LeadIQ.

What industry does Epivara belong to?

Minus sign iconPlus sign icon
Epivara operates in the Pharmaceutical Manufacturing industry.

What technology does Epivara use?

Minus sign iconPlus sign icon
Epivara's tech stack includes QuickBooks, Usercentrics, Wix, WordPress, Wix eCommerce, Google Workspace, Google Cloud and Sentry.

What is Epivara's email format?

Minus sign iconPlus sign icon
Epivara's email format typically follows the pattern of First@epivara.com. Find more Epivara email formats with LeadIQ.

How much funding has Epivara raised to date?

Minus sign iconPlus sign icon
As of November 2026, Epivara has raised $8.8M in funding. The last funding round occurred on Feb 18, 2025 for $4M.

When was Epivara founded?

Minus sign iconPlus sign icon
Epivara was founded in 2016.
Epivara logo

Epivara

Pharmaceutical ManufacturingIllinois, United States11-50 Employees

Epivara, a pharmaceutical manufacturing company based in Champaign, Illinois, focuses on humane, non-surgical methods for animal sterilization. Its flagship approach, iSpay and iNeuter, is designed to provide a simple, single-injection alternative to traditional spay/neuter procedures, with the aim of reducing animal discomfort and recovery time while offering a cost-effective solution for shelters, breeders, and farmers. The technology seeks to lower aggressive and sexual behaviors by suppressing hormone production, ultimately contributing to animal health, overpopulation control, and welfare in dogs, cats, and livestock.

Operating within the animal health and veterinary biotechnology sector, Epivara positions itself as a provider of innovative, non-invasive sterilization options that can be deployed across shelters, farms, and veterinary settings. The company has pursued early-stage research and development activities and has engaged with government-backed SBIR programs, reflecting its focus on advancing non-surgical sterilization methods for both female and male animals. Epivara has a presence in the U.S. market and emphasizes its rebranding from its former name, InSigna, while continuing to pursue its mission through scientific development and practical applications.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $8.8M

    Epivara has raised a total of $8.8M of funding over 5 rounds. Their latest funding round was raised on Feb 18, 2025 in the amount of $4M as a Venture Round.

  • $1M - $10M

    Epivara's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.